4.7 Article

Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator

Michael M. Jonczyk et al.

Summary: This study aimed to assess predictors of acute postoperative complications for breast cancer patients and develop a predictive model that calculates complication probability using patient risk factors. The models built showed good performance in predicting various types of complications with high accuracy and calibration measures. The risk calculator developed has the potential to help stratify patients with higher complication risks and improve decision-making process expectations.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

National trends of synchronous bilateral breast cancer incidence in the United States

Takehiko Sakai et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Medicine, General & Internal

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

J. A. Sparano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Oncology

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

Charles E. Geyer et al.

NPJ BREAST CANCER (2018)

Review Oncology

Molecular Genomic Testing for Breast Cancer: Utility for Surgeons

Oluwadamilola M. Fayanju et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Article Oncology

Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer

Maria Karsten et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Article Oncology

Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?

Jeffrey G. Schneider et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Article Oncology

Incidence and prognosis of synchronous and Metachronous bilateral breast cancer

Mikael Hartman et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Medicine, General & Internal

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

S Paik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)